Choline Supplementation for Child Development
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether taking a choline supplement during pregnancy can enhance early brain development in children. The study will compare the effects of the supplement against a placebo to determine any differences in children’s behavior and other developmental milestones by age four. Pregnant women who are physically healthy and do not have chronic infections or a history of certain genetic conditions might be suitable candidates for this trial. Participants will take either the choline supplement or a placebo from about the 16th week of pregnancy until delivery. The goal is to assess whether the supplement can support better cognitive, motor, and socio-emotional growth in young children. As a Phase 1 trial, this research focuses on understanding how the choline supplement works in people, offering participants the opportunity to be among the first to receive this treatment.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your healthcare provider.
Is there any evidence suggesting that this treatment is likely to be safe for humans?
Research has shown that taking choline supplements during pregnancy is generally safe. Choline plays a crucial role in the baby's brain development. Pregnant women who have taken choline supplements have not reported major negative effects.
Most children and adults tolerate choline well. Studies suggest that doses up to 1 gram per day are safe for children. This information indicates it is likely safe for pregnant women, even though the doses in this trial are higher.
Although detailed information about side effects during pregnancy is limited, the absence of serious problems in past studies is reassuring. Always consult a healthcare provider before starting any supplement.12345Why do researchers think this study treatment might be promising?
Researchers are excited about choline supplementation for child development because it introduces a promising approach to supporting brain growth. Unlike standard prenatal vitamins, which may not include choline, this treatment specifically targets brain development by providing an essential nutrient directly linked to cognitive function. Choline is crucial for the formation of cell membranes and the production of neurotransmitters, making it a vital component for developing a healthy nervous system. By directly supplementing phosphatidylcholine, this treatment could offer a more targeted and efficient way to enhance fetal brain development compared to conventional prenatal care.
What evidence suggests that choline supplementation might be an effective treatment for child development?
Research has shown that taking choline supplements during pregnancy may support the baby's brain development. Some studies suggest that choline could improve memory and intelligence by affecting the hippocampus, a brain region involved in these functions. However, other research has found mixed results, with some studies showing little or no benefit for children's brain development. Despite this, adequate choline intake during pregnancy remains important for the baby's overall brain health. This trial will compare the effects of choline supplementation with a placebo to further investigate its impact on brain development. While the data appears promising, more research is needed to fully understand how choline affects brain development.12367
Who Is on the Research Team?
Camille Hoffman, MD
Principal Investigator
University of Colorado, Denver
Are You a Good Fit for This Trial?
This trial is for healthy pregnant women aged 18-45 with a normal BMI, who speak English or Spanish. It's not suitable for those with a history of fetal death, chronic infections like HIV, certain genetic disorders, or noncompliance issues.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either 1250 mg of choline or placebo daily from approximately 16 weeks gestation until delivery
Follow-up
Children are monitored and assessed for developmental outcomes until 4 years of age
What Are the Treatments Tested in This Trial?
Interventions
- Choline
- Placebo
Choline is already approved in United States, European Union, Canada for the following indications:
- Dietary supplement
- Dietary supplement
- Dietary supplement
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Colorado, Denver
Lead Sponsor